SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
无奈的醉冬
Lv1
40 积分
2024-04-10 加入
最近求助
最近应助
互助留言
Donanemab in Early Alzheimer's Disease
12天前
已完结
Association of Amyloid Reduction After Donanemab Treatment With Tau Pathology and Clinical Outcomes: The TRAILBLAZER-ALZ Randomized Clinical Trial
12天前
已完结
Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ Randomized Clinical Trial
12天前
已完结
Use of Donanemab in Early Symptomatic Alzheimer Disease
12天前
已完结
How promising are the latest monoclonal antibodies targeting amyloid-β for the treatment of early Alzheimer's disease?
12天前
已完结
Development of amyloid beta-directed antibodies against Alzheimer's disease: Twists and turns
12天前
已完结
Development of amyloid beta-directed antibodies against Alzheimer's disease: Twists and turns
12天前
已关闭
Substantial Doubt Remains about the Efficacy of Anti-Amyloid Antibodies
12天前
已完结
Promising advances in Alzheimer's treatment: donanemab's impact on disease progression and amyloid clearance
12天前
已完结
Risk factors in developing amyloid related imaging abnormalities (ARIA) and clinical implications
12天前
已完结
没有进行任何应助
感谢
12天前
感谢
12天前
感谢
12天前
感谢
12天前
感谢
12天前
感谢
12天前
感谢
13天前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论